ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

In Brief: McIntyre To Replace Frei As Group Chairman Abeloff, Murphy Nominated For ASCO Presidency

January 26, 1990

Nurse Participation In International Congress Increases

September 19, 1986

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

Funding Opportunities (12-page issue).

May 16, 2003